# Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata

> **NCT05885269** · PHASE1 · COMPLETED · sponsor: **Combined Military Hospital Abbottabad** · enrollment: 70 (actual)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Group A applied topical Clobetasol Propionate
- **DRUG:** Group B applied topical Tacrolimus

## Key facts

- **NCT ID:** NCT05885269
- **Lead sponsor:** Combined Military Hospital Abbottabad
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-01
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05885269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05885269, "Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05885269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*